386 related articles for article (PubMed ID: 17689933)
21. Bacteraemia in neutropenic patients.
O'Connell B; Daly PA; McCann SR; Keane CT
Ir Med J; 1993; 86(6):203-5. PubMed ID: 8106229
[TBL] [Abstract][Full Text] [Related]
22. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia.
Lehrnbecher T; Venzon D; de Haas M; Chanock SJ; Kühl J
Clin Infect Dis; 1999 Aug; 29(2):414-9. PubMed ID: 10476751
[TBL] [Abstract][Full Text] [Related]
23. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology and clinical outcome of enterococcal bacteraemia in an acute care hospital.
Poh CH; Oh HM; Tan AL
J Infect; 2006 May; 52(5):383-6. PubMed ID: 16203039
[TBL] [Abstract][Full Text] [Related]
25. Microbiological data for patients with febrile neutropenia.
Kanamaru A; Tatsumi Y
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S7-S10. PubMed ID: 15250014
[TBL] [Abstract][Full Text] [Related]
26. Risk of bacteraemia and mortality in patients with haematological malignancies.
Nørgaard M; Larsson H; Pedersen G; Schønheyder HC; Sørensen HT
Clin Microbiol Infect; 2006 Mar; 12(3):217-23. PubMed ID: 16451407
[TBL] [Abstract][Full Text] [Related]
27. Moxifloxacin prophylaxis in neutropenic patients.
von Baum H; Sigge A; Bommer M; Kern WV; Marre R; Döhner H; Kern P; Reuter S
J Antimicrob Chemother; 2006 Oct; 58(4):891-4. PubMed ID: 16880172
[TBL] [Abstract][Full Text] [Related]
28. [Infectious complications in pediatric cancer patients].
Lehrnbecher T; Laws HJ
Klin Padiatr; 2005 Nov; 217 Suppl 1():S3-8. PubMed ID: 16288349
[TBL] [Abstract][Full Text] [Related]
29. Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital.
Metan G; Hayran M; Hascelik G; Uzun O
Scand J Infect Dis; 2006; 38(6-7):527-31. PubMed ID: 16798705
[TBL] [Abstract][Full Text] [Related]
30. Bacteraemia among severely malnourished children infected and uninfected with the human immunodeficiency virus-1 in Kampala, Uganda.
Bachou H; Tylleskär T; Kaddu-Mulindwa DH; Tumwine JK
BMC Infect Dis; 2006 Nov; 6():160. PubMed ID: 17090299
[TBL] [Abstract][Full Text] [Related]
31. Surveillance study of bacteraemic episodes in febrile neutropenic children.
Ariffin H; Navaratnam P; Lin HP
Int J Clin Pract; 2002 May; 56(4):237-40. PubMed ID: 12074201
[TBL] [Abstract][Full Text] [Related]
32. Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases.
Malagola M; Peli A; Damiani D; Candoni A; Tiribelli M; Martinelli G; Piccaluga PP; Paolini S; De Rosa F; Lauria F; Bocchia M; Gobbi M; Pierri I; Zaccaria A; Zuffa E; Mazza P; Priccolo G; Gugliotta L; Bonini A; Visani G; Skert C; Bergonzi C; Roccaro AM; Filì C; Fanin R; Baccarani M; Russo D
Eur J Haematol; 2008 Nov; 81(5):354-63. PubMed ID: 18637030
[TBL] [Abstract][Full Text] [Related]
33. Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey.
Tezcan G; Kupesiz A; Ozturk F; Ogunc D; Gultekin M; Yesilipek A; Hazar V
Pediatr Hematol Oncol; 2006; 23(3):217-29. PubMed ID: 16517538
[TBL] [Abstract][Full Text] [Related]
34. Risk assessment and microbiological profile of infections in paediatric cancer patients with febrile neutropenia.
Latiff Z; Zulkifli SZ; Jamal R
Malays J Pathol; 2002 Dec; 24(2):83-9. PubMed ID: 12887165
[TBL] [Abstract][Full Text] [Related]
35. [Neutropenia and sepsis in hematologic patients].
Egyed M; Kollár B; Karádi E; Rajnics P; Kocsondi L; Rumi G
Orv Hetil; 2006 Oct; 147(42):2031-3. PubMed ID: 17165603
[TBL] [Abstract][Full Text] [Related]
36. Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis.
Cherif H; Kronvall G; Björkholm M; Kalin M
Hematol J; 2003; 4(6):420-6. PubMed ID: 14671614
[TBL] [Abstract][Full Text] [Related]
37. Immediate vs. delayed imipenem treatment in cancer patients with profound neutropenia induced by high-dose chemotherapy: results of a randomized study.
García-Sáenz JA; Martín M; Casado A; Pérez-Segura P; Manrique I; Flores L; Macias JA; Cámara JC; Perezagua C; Díaz-Rubio E
Rev Esp Quimioter; 2002 Sep; 15(3):257-63. PubMed ID: 12582429
[TBL] [Abstract][Full Text] [Related]
38. Gram-negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT): risk factors, prophylaxis, therapy and outcome.
Mitchell AE; Derrington P; Turner P; Hunt LP; Oakhill A; Marks DI
Bone Marrow Transplant; 2004 Feb; 33(3):303-10. PubMed ID: 14647252
[TBL] [Abstract][Full Text] [Related]
39. Management of fever in neutropenic patients with different risks of complications.
Klastersky J
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S32-7. PubMed ID: 15250018
[TBL] [Abstract][Full Text] [Related]
40. Mortality associated with bloodstream infection after coronary artery bypass surgery.
Olsen MA; Krauss M; Agniel D; Schootman M; Gentry CN; Yan Y; Damiano RJ; Fraser VJ
Clin Infect Dis; 2008 May; 46(10):1537-46. PubMed ID: 18419488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
